Alefacept

Details

Files

Generic Name:

Alefacept

Project Status:

Complete

Therapeutic Area:

Psoriasis, moderate to severe chronic plaque

Manufacturer:

Biogen Idec Canada Inc.

Brand Name:

Amevive

Project Line:

Reimbursement Review

Project Number:

SR0024-000

Submission Type:

Initial

Indications:

Psoriasis, moderate to severe chronic plaque

Recommendation Type:

Do not list

Final Recommendation:

May 26, 2005

Recommendation:

Not to list

Files

Submission Status Report View PDF

Recommendation and Reasons View PDF

Last Updated : November 16, 2004